Skip to Main Content

Paper Details

Identification of the ultrahigh-risk subgroup in neuroblastoma cases through DNA methylation analysis and its treatment exploiting cancer metabolism.
Oncogene
5
2022
Author NameAffiliation
Hiroko TanakaTokyo Medical and Dental University
Satoru MiyanoTokyo Medical and Dental University
Hiromichi SuzukiGraduate School of Medicine, Kyoto University
Hiromichi SuzukiNational Cancer Center Research Institute
Satoru MiyanoResearch Center for Advanced Science and Technology, The University of Tokyo
Seishi OgawaGraduate School of Medicine, Kyoto University
Seishi OgawaInstitute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University
  • 1 - 7

Datasets

Release 1.2